Document Detail


A possible strategy against head and neck cancer: in silico investigation of three-in-one inhibitors.
MedLine Citation:
PMID:  23140436     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Overexpression of epidermal growth factor receptor (EGFR), Her2, and uroporphyrinogen decarboxylase (UROD) occurs in a variety of malignant tumor tissues. UROD has potential to modulate tumor response of radiotherapy for head and neck cancer, and EGFR and Her2 are common drug targets for the treatment of head and neck cancer. This study attempts to find a possible lead compound backbone from TCM Database@Taiwan ( http://tcm.cmu.edu.tw/ ) for EGFR, Her2, and UROD proteins against head and neck cancer using computational techniques. Possible traditional Chinese medicine (TCM) lead compounds had potential binding affinities with EGFR, Her2, and UROD proteins. The candidates formed stable interactions with residues Arg803, Thr854 in EGFR, residues Thr862, Asp863 in Her2 protein, and residues Arg37, Arg41 in UROD protein, which are key residues in the binding or catalytic domain of EGFR, Her2, and UROD proteins. Thus, the TCM candidates indicated a possible molecule backbone for evolving potential inhibitors for three drug target proteins against head and neck cancer. An animated interactive 3D complement (I3DC) is available in Proteopedia at http://proteopedia.org/w/Journal:JBSD:35.
Authors:
Yung-An Tsou; Kuan-Chung Chen; Su-Sen Chang; Yeong-Ray Wen; Calvin Yu-Chian Chen
Related Documents :
19959026 - Cancer genesis across the age spectrum: associations with tissue development, maintenan...
23696216 - Deubiquitinase inhibition of 19s regulatory particles by 4-arylidene curcumin analogue ...
20217596 - Synthesis, characterization, and functionalization of gold nanoparticles for cancer ima...
23089186 - Age dependent increase in prostaglandin pathway coincides with onset of ovarian cancer ...
2638566 - Occupational exposure to organic solvents causing chronic tubulointerstitial nephritis.
20103726 - Assessing efficacy in early-phase cancer prevention clinical trials: the case of ki-67 ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-12
Journal Detail:
Title:  Journal of biomolecular structure & dynamics     Volume:  -     ISSN:  1538-0254     ISO Abbreviation:  J. Biomol. Struct. Dyn.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8404176     Medline TA:  J Biomol Struct Dyn     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
a Laboratory of Computational and Systems Biology , China Medical University , Taichung , 40402 , Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Spectroscopic and computational studies of a small-molecule functional mimic of iron superoxide dism...
Next Document:  Evaluation of two working methods for screed floor layers on musculoskeletal complaints, work demand...